Table 1.
Characteristics of CAHPS respondents diagnosed with leukemia and lymphoma.
| Diagnosis | |||
|---|---|---|---|
| Leukemia (n=431) | Lymphoma (n= 720) | ||
| Characteristic | No. (%) | No. (%) | p-valuea |
| Age at diagnosis | .32 | ||
| 65–69 | 68 (15.8) | 138 (19.2) | |
| 70–74 | 112 (26.0) | 160 (22.2) | |
| 75–79 | 97 (22.5) | 171 (23.8) | |
| 80–84 | 80 (18.6) | 144 (20.0) | |
| 85+ | 74 (17.1) | 107 (14.8) | |
| Sex | <.001 | ||
| Male | 249 (57.7) | 331 (45.9) | |
| Female | 182 (42.3) | 389 (54.1) | |
| Race/Ethnicity | <.01 | ||
| Non-Hispanic White | 374 (86.8) | 621 (86.2) | |
| Non-Hispanic Black | 28 (6.5) | 27 (3.8) | |
| Hispanic and Non-Hispanic American Indian/Alaska Native, Asian, Pacific Islander | 29 (6.7) | 72 (10.0)) | |
| Education | .03 | ||
| 8th grade to high school | 80 (18.6) | 178 (24.7) | |
| High school graduate or GED | 115 (26.7) | 216 (30.0) | |
| Some college or higher | 208 (48.3) | 283 (39.3) | |
| Unknown | 28 (6.4) | 43 (6.0) | |
| SEER region at diagnosis | .30 | ||
| Northeast | 85 (19.7) | 126 (17.5) | |
| Midwest | 35 (8.1) | 54 (7.5) | |
| South | 73 (17.0) | 154 (21.4) | |
| West | 238 (55.2) | 386 (53.6) | |
| Comorbidity count** | .49 | ||
| 0 | 321 (74.5) | 530 (73.6) | |
| 1 | 69 (16.0) | 132 (18.3) | |
| 2+ | 41 (9.5) | 58 (8.1) | |
| Time from diagnosis to survey, months | .01 | ||
| 0–3 | 152 (32.3) | 196 (27.2) | |
| 4–7 | 122 (28.3) | 246 (34.2) | |
| 8–12 | 157 (36.4) | 278 (38.6) | |
| General health status | .63 | ||
| Excellent, very good, good | 287 (66.6) | 501 (69.6) | |
| Fair/poor | 131 (30.4) | 194 (26.9) | |
| Unknown | 13 (3.0) | 25 (3.5) | |
| Mental health status | .22 | ||
| Excellent, very good, good | 348 (80.7) | 594 (82.5) | |
| Fair/poor | 45 (10.4) | 57 (7.9) | |
| Unknown | 38 (8.9) | 69 (9.6) | |
| Urban/rural residency at diagnosis | .65 | ||
| Big Metro, Metro, Urban | 408 (94.7) | 666 (92.5) | |
| Less Urban, Rural | 23 (5.3) | 54 (7.5) | |
| Did a proxy help complete survey | .98 | ||
| No | 309 (71.7) | 514 (71.4) | |
| Yes | 55 (12.8) | 91 (12.6) | |
| Unknown | 67 (15.5) | 115 (16.0) | |
| Medicaid dual eligibility | .84 | ||
| No | 393 (91.2) | 654 (90.8) | |
| Yes | 38 (8.8) | 66 (9.2) | |
| Medicare advantage indicator | .73 | ||
| FFS type or PDP | 184 (42.7) | 300 (41.7) | |
| MA type | 247 (57.3) | 420 (58.3) | |
| Disease severity indicator | <.001 | ||
| No | 267 (62.1) | 673 (93.5) | |
| Yes | 164 (37.9) | 47 (6.5) | |
| Percentage of census tract in poverty | .17 | ||
| 0–<5% poverty | 115 (26.7) | 190 (26.3) | |
| 5–<10% poverty | 131 (30.4) | 183 (25.4) | |
| 10–<20% poverty | 123 (28.5) | 243 (33.8) | |
| 20–100% poverty | 62 (14.4) | 100 (13.9) | |
Abbreviations: CAHPS, Consumer Assessment of Healthcare Providers and Systems Survey; GED, general education development; SEER, surveillance epidemiology end-results registry.
a
Pearson Chi-square test p-value.